Menopausal Hormone Therapy and Risk of Endometrial Cancer: A Systematic Review.

Clemens B TempferZiad HilalPeter KernIngolf Juhasz-BoessGünther A Rezniczek

Published in: Cancers (2020)

ccMHT with SPs reduces the risk of EC, whereas estrogen-only MHT increases the risk. scMHT with SPs and cc/scMHT with micronized progesterone increase the risk of EC depending on type of progestin, progestin dosage, and duration of MHT use.

Keyphrases

endometrial cancer
estrogen receptor